ArriVent BioPharma (AVBP) Stock Insights
AVBP$15.51+0.11 +0.71%
$764.76M
Market Cap
-5.71
P/E
—
Forward P/E
55
Score
ArriVent BioPharma (AVBP) Stock Insights
AVBP price $15.51 +0.11 +0.71%
- Ticker
- AVBP
- Price
- $15.51
- Change
- +0.11 +0.71%
- Market cap ?
- $764.76M
- P/E ?
- -5.71
- Dividend yield ?
- 0.00%
- Beta ?
- 1.35
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 55
- Value
- 56
- Quality
- 49
- Growth
- 60
Stocklytics score rationale: value 56, quality 49, growth 60.
Financials
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 |
ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. The company’s lead development candidate is firmonertinib, a tyrosine kinase inhibitor that is being evaluated in multiple clinical trials across a range of epidermal growth factor receptor mutations (EGFRm) in…
Fair value
AVBP fair value Not meaningful. Price $15.51.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-16 | — | -1.04 | — | 800.00K |
| 2026-08-12 | -1.05 | -0.99 | — | — |
| 2026-05-11 | -0.96 | -0.88 | — | — |
| 2026-03-05 | -0.78 | -0.87 | — | — |
| 2025-11-10 | -0.83 | -0.78 | — | — |
| 2025-08-11 | -0.90 | -0.70 | — | — |
| 2025-05-12 | -1.90 | -0.66 | — | — |
| 2025-03-03 | -0.60 | -0.78 | — | — |
| 2024-11-14 | -0.61 | -0.82 | — | — |
| 2024-08-14 | -0.65 | -0.65 | — | — |
| 2024-05-08 | -0.70 | -0.84 | — | — |
| 2024-03-28 | -5.30 | -0.65 | — | — |
| 2023-09-30 | -0.43 | — | — | — |
| 2023-08-25 | -0.64 | — | — | — |
| 2023-03-31 | -0.36 | — | — | — |
| 2022-12-30 | -0.31 | — | — | — |
| 2022-09-29 | -0.35 | — | — | — |
| 2022-06-30 | -5.76 | — | — | — |
| 2022-03-31 | -5.76 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-18 | Parsey Merdad | Buy | 13.56K | $31.74 | 430.46K |
| 2026-06-18 | Peterson Kristine | Buy | 13.56K | $31.74 | 430.46K |
| 2026-06-18 | Hohneker John | Buy | 13.56K | $31.74 | 430.46K |
| 2026-06-18 | Nolet Chris | Buy | 13.56K | $31.74 | 430.46K |
| 2026-02-02 | LaChapelle Robin | Buy | 130.00K | $22.67 | 2.95M |
| 2026-02-02 | Lutzker Stuart | Buy | 150.00K | $22.67 | 3.40M |
| 2026-02-02 | Kung Winston | Buy | 140.00K | $22.67 | 3.17M |
| 2026-02-02 | Yao Zhengbin | Buy | 550.00K | $22.67 | 12.47M |
| 2026-02-02 | Kastenmayer James Paul | Buy | 130.00K | $22.67 | 2.95M |
| 2025-12-10 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Sell | 555.55K | $23.37 | 12.98M |
| 2025-07-11 | LaChapelle Robin | Buy | 6.50K | $2.28 | 14.83K |
| 2025-07-11 | LaChapelle Robin | Buy | 2.60K | $2.28 | 5.93K |
| 2025-07-11 | LaChapelle Robin | Buy | 2.05K | $2.28 | 4.67K |
| 2025-07-11 | LaChapelle Robin | Sell | 2.60K | $2.28 | 5.93K |
| 2025-07-11 | LaChapelle Robin | Sell | 6.50K | $2.28 | 14.83K |
| 2025-07-11 | LaChapelle Robin | Sell | 2.05K | $2.28 | 4.67K |
| 2025-06-18 | Parsey Merdad | Buy | 15.50K | $24.89 | 385.84K |
| 2025-06-18 | Peterson Kristine | Buy | 15.50K | $24.89 | 385.84K |
| 2025-06-18 | Hohneker John | Buy | 15.50K | $24.89 | 385.84K |
| 2025-06-18 | Nolet Chris | Buy | 15.50K | $24.89 | 385.84K |
| 2025-04-28 | Parsey Merdad | Buy | 28.35K | $20.92 | 593.00K |
| 2025-04-28 | Parsey Merdad | Other | 0 | — | — |
| 2025-02-03 | Yao Zhengbin | Buy | 380.00K | $27.56 | 10.47M |
| 2025-02-03 | Lutzker Stuart | Buy | 120.00K | $27.56 | 3.31M |
| 2025-02-03 | LaChapelle Robin | Buy | 120.00K | $27.56 | 3.31M |
| 2025-02-03 | Kung Winston | Buy | 120.00K | $27.56 | 3.31M |
| 2025-02-03 | Kastenmayer James Paul | Buy | 102.00K | $27.56 | 2.81M |
| 2024-09-19 | LaChapelle Robin | Buy | 12.36K | $3.65 | 45.13K |
| 2024-09-19 | LaChapelle Robin | Buy | 2.47K | $2.28 | 5.63K |
| 2024-09-19 | LaChapelle Robin | Buy | 7.16K | $2.28 | 16.33K |
| 2024-09-19 | LaChapelle Robin | Buy | 2.87K | $2.28 | 6.54K |
| 2024-09-19 | LaChapelle Robin | Buy | 2.70K | $6.24 | 16.85K |
| 2024-09-19 | LaChapelle Robin | Sell | 2.70K | $6.24 | 16.85K |
| 2024-09-19 | LaChapelle Robin | Sell | 2.87K | $2.28 | 6.54K |
| 2024-09-19 | LaChapelle Robin | Sell | 12.36K | $3.65 | 45.13K |
| 2024-09-19 | LaChapelle Robin | Sell | 7.16K | $2.28 | 16.33K |
| 2024-09-19 | LaChapelle Robin | Sell | 2.47K | $2.28 | 5.63K |
| 2024-05-16 | Hohneker John | Buy | 29.55K | $20.15 | 595.43K |
| 2024-05-16 | Hohneker John | Other | 0 | — | — |
| 2024-04-22 | Peterson Kristine | Buy | 28.59K | $15.90 | 454.53K |
| 2024-04-20 | Peterson Kristine | Other | 0 | — | — |
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Buy | 555.55K | $18.00 | 10.00M |
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Buy | 313.08K | — | — |
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Buy | 3.62M | — | — |
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Sell | 4.76M | — | — |
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Sell | 55.00M | — | — |
| 2024-01-30 | ORBIMED ADVISORS LLC | Buy | 222.22K | $18.00 | 4.00M |
| 2024-01-30 | ORBIMED ADVISORS LLC | Buy | 469.62K | — | — |
| 2024-01-30 | ORBIMED ADVISORS LLC | Buy | 821.83K | — | — |
| 2024-01-30 | ORBIMED ADVISORS LLC | Sell | 469.62K | — | — |
| 2024-01-30 | ORBIMED ADVISORS LLC | Sell | 821.83K | — | — |
| 2024-01-30 | GORDON CARL L | Buy | 222.22K | $18.00 | 4.00M |
| 2024-01-30 | GORDON CARL L | Buy | 469.62K | — | — |
| 2024-01-30 | GORDON CARL L | Buy | 821.83K | — | — |
| 2024-01-30 | GORDON CARL L | Sell | 821.83K | — | — |
| 2024-01-30 | GORDON CARL L | Sell | 469.62K | — | — |
| 2024-01-30 | HEALY JAMES | Buy | 444.44K | $18.00 | 8.00M |
| 2024-01-30 | HEALY JAMES | Buy | 1.25M | — | — |
| 2024-01-30 | HEALY JAMES | Sell | 1.25M | — | — |
| 2024-01-25 | Nolet Chris | Buy | 17.88K | $18.00 | 321.91K |
| 2024-01-25 | Jallal Bahija | Buy | 17.88K | $18.00 | 321.91K |
| 2024-01-25 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Other | 313.08K | — | — |
| 2024-01-25 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | Other | 3.62M | — | — |
| 2024-01-25 | ORBIMED ADVISORS LLC | Other | 821.83K | — | — |
| 2024-01-25 | ORBIMED ADVISORS LLC | Other | 469.62K | — | — |
| 2024-01-25 | Yao Zhengbin | Other | 0 | — | — |
| 2024-01-25 | Yao Zhengbin | Other | 0 | — | — |
| 2024-01-25 | Yao Zhengbin | Other | 141.35K | $2.28 | 322.28K |
| 2024-01-25 | Yao Zhengbin | Other | 141.35K | $3.65 | 515.94K |
| 2024-01-25 | Yao Zhengbin | Other | 264.57K | $7.76 | 2.05M |
| 2024-01-25 | Nolet Chris | Sell | 16.44K | $6.24 | 102.56K |
| 2024-01-25 | Lutzker Stuart | Other | 0 | — | — |
| 2024-01-25 | Lutzker Stuart | Other | 42.73K | $2.28 | 97.44K |
| 2024-01-25 | Lutzker Stuart | Other | 42.73K | $3.65 | 155.98K |
| 2024-01-25 | Lutzker Stuart | Other | 49.31K | $7.76 | 382.64K |
| 2024-01-25 | LaChapelle Robin | Other | 0 | — | — |
| 2024-01-25 | LaChapelle Robin | Other | 0 | — | — |
| 2024-01-25 | LaChapelle Robin | Other | 49.31K | $7.76 | 382.64K |
| 2024-01-25 | LaChapelle Robin | Other | 18.22K | $2.28 | 41.53K |
| 2024-01-25 | LaChapelle Robin | Other | 31.23K | $3.65 | 113.99K |
| 2024-01-25 | LaChapelle Robin | Other | 59.17K | $6.24 | 369.23K |
| 2024-01-25 | Kung Winston | Sell | 197.24K | $7.76 | 1.53M |
| 2024-01-25 | Kastenmayer James Paul | Sell | 0 | — | — |
| 2024-01-25 | Kastenmayer James Paul | Sell | 32.87K | $7.76 | 255.09K |
| 2024-01-25 | Kastenmayer James Paul | Sell | 65.75K | $6.24 | 410.25K |
| 2024-01-25 | HEALY JAMES | Other | 1.25M | — | — |
| 2024-01-25 | GORDON CARL L | Other | 821.83K | — | — |
| 2024-01-25 | GORDON CARL L | Other | 469.62K | — | — |
| 2024-01-25 | Jallal Bahija | Other | 13.15K | $2.28 | 29.98K |
| 2024-01-25 | Jallal Bahija | Other | 6.57K | $3.65 | 24.00K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 166, holders +21 vs prior quarter. Ownership 103.02%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 4.52M | 114.45K | +2.60% | 156.87M |
| INFINITUM ASSET MANAGEMENT, LLC | 4.44M | 289.46K | +6.98% | 154.19M |
| HHLR ADVISORS, LTD. | 3.93M | 0 | 0.00% | 136.50M |
| BLACKROCK, INC. | 3.25M | 720.10K | +28.46% | 112.92M |
| ORBIMED ADVISORS LLC | 3.03M | 0 | 0.00% | 105.17M |
| FMR LLC | 2.78M | -237.17K | -7.86% | 96.54M |
| OCTAGON CAPITAL ADVISORS LP | 1.97M | 0 | 0.00% | 68.47M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.77M | 245.98K | +16.09% | 61.66M |
| SOFINNOVA INVESTMENTS, INC. | 1.70M | 0 | 0.00% | 58.95M |
| STATE STREET CORP | 1.69M | 271.57K | +19.11% | 58.81M |
| VIVO CAPITAL, LLC | 1.68M | 796.18K | +89.87% | 58.44M |
| NOVO HOLDINGS A/S | 1.50M | -442.14K | -22.77% | 52.11M |
| GENERAL CATALYST GROUP MANAGEMENT, LLC | 1.49M | 0 | 0.00% | 51.93M |
| LOGOS GLOBAL MANAGEMENT LP | 1.00M | 650.00K | +185.71% | 34.74M |
| GEODE CAPITAL MANAGEMENT, LLC | 972.63K | 168.97K | +21.03% | 33.80M |
| D. E. SHAW & CO., INC. | 872.01K | 503.22K | +136.45% | 30.29M |
| GOLDMAN SACHS GROUP INC | 853.72K | 296 | +0.03% | 29.66M |
| HSG HOLDING LTD | 663.31K | 0 | 0.00% | 23.04M |
| POINT72 ASSET MANAGEMENT, L.P. | 566.80K | -181.40K | -24.24% | 19.69M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 508.30K | 479.50K | +1664.93% | 17.66M |
| MILLENNIUM MANAGEMENT LLC | 438.66K | 12.74K | +2.99% | 15.24M |
| UBS GROUP AG | 438.59K | -47.67K | -9.80% | 15.24M |
| BALYASNY ASSET MANAGEMENT L.P. | 395.45K | -30.83K | -7.23% | 13.74M |
| AMERIPRISE FINANCIAL INC | 381.59K | 201.56K | +111.96% | 13.26M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 335.32K | 81.47K | +32.09% | 11.65M |
Insights · Dividends · Forecast · Financials · Learn